Bortezomib in Treating Patients With Newly Diagnosed Multiple Myeloma
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well bortezomib works in treating patients with newly
diagnosed multiple myeloma. Bortezomib may stop the growth of cancer cells by blocking some
of the enzymes needed for cell growth.